Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > March 17, 2023
Daily News
March 17, 2023
- Revision of Guidelines on Drone Drug Deliveries Expected by March-End: Will Powerful Meds Be OK'ed?
March 17, 2023
- Takeda Updates Qdenga Peak Sales Estimate to US$1.6-2 Billion
March 17, 2023
- 97 Health Damages Reported for Kymriah in Japan: April-September
March 17, 2023
- Fujifilm to Make Foray into Drug Discovery CRO Business
March 17, 2023
- Twymeeg No 1 in GP Promotion in January, Dayvigo Most Pitched for HP: Intage
March 17, 2023
- Japan to Add Purchased Doses of Paxlovid, Xocova to Govt Stockpile
March 17, 2023
- Health Minister Vows to Make Use of Govt-Purchased Xocova
March 17, 2023
- CSL R&D Head Touts Cost-Effectiveness of Hemophilia Gene Therapy Hemgenix
March 17, 2023
Japan’s pharmaceutical industry could be on the verge of gaining a stronger voice in the Central Social Insurance Medical Council…
Let’s face it: in today’s world, changing jobs is a normal part of a successful career. But if it’s so normal, why does it feel so hard? For many people, the idea of leaving their current role brings a heavy…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…